233. Wolfram syndrome Clinical trials / Disease details
Clinical trials : 11 / Drugs : 17 - (DrugBank : 8) / Drug target genes : 12 - Drug target pathways : 41
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05676034 (ClinicalTrials.gov) | March 2023 | 22/12/2022 | AMX0035 in Adult Patients With Wolfram Syndrome | A Phase II Study of Safety and Efficacy of AMX0035 in Adult Patients With Wolfram Syndrome | Wolfram Syndrome | Drug: AMX0035 | Amylyx Pharmaceuticals Inc. | NULL | Recruiting | 17 Years | N/A | All | 12 | Phase 2 | United States |